ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects & Related Topics -- Volume 2
Editat de Macaulay Amechi Onuigboen Limba Engleză Hardback – 2015
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Hardback (3) | 902.43 lei 3-5 săpt. | |
| Nova Science Publishers Inc – 2015 | 902.43 lei 3-5 săpt. | |
| Nova Science Publishers Inc – dec 2013 | 1217.63 lei 3-5 săpt. | |
| Nova Science Publishers Inc – 2015 | 1430.68 lei 3-5 săpt. |
Preț: 902.43 lei
Preț vechi: 1099.41 lei
-18%
Puncte Express: 1354
Preț estimativ în valută:
159.53€ • 186.76$ • 139.31£
159.53€ • 186.76$ • 139.31£
Carte disponibilă
Livrare economică 13-27 februarie
Specificații
ISBN-13: 9781634637022
ISBN-10: 163463702X
Pagini: 373
Dimensiuni: 180 x 260 x 21 mm
Greutate: 0.69 kg
Editura: Nova Science Publishers Inc
Colecția Nova Science Publishers, Inc (US)
Locul publicării:United States
ISBN-10: 163463702X
Pagini: 373
Dimensiuni: 180 x 260 x 21 mm
Greutate: 0.69 kg
Editura: Nova Science Publishers Inc
Colecția Nova Science Publishers, Inc (US)
Locul publicării:United States
Cuprins
Foreword; Preface; Chronotherapy of Hypertension with ACEIs & CKD: A New Solution to an Old Problem; ACEIs as Antihypertensives in African Americans: A 21st Century Perspective; Angiotensin-Converting Enzyme Inhibitors: A Seattle Internists Perspective; ACEIs in Cardiovascular Medicine: A 21st Century Caribbean Perspective; ACEIs as Antihypertensives: A Nigerian CKD Clinic Experience; ACEIs as Antihypertensives in the Elderly (>65 Year Old): A South American Perspective; The Impact of Salt Restriction on the Effectiveness of Antihypertensive Therapy; Are ARBs the Preferred Agents to Treat Hypertension in Patients with HIV-Nephropathy with Albuminuria?; The Use of ACEIs & ARBs in ESRD Patients on Maintenance Hemodialysis & Peritoneal Dialysis; The Use of Angiotensin-Converting Enzyme Inhibitors in the Renal Transplant Recipient; ACE Inhibition & Renal Artery Stenosis: What Lessons Have we Learnt? A 21st Century Perspective; Angiotensin-Converting Enzyme Inhibitors in Renal Disease: A European Perspective; Angiotensin-Converting Enzyme Inhibitors in Heart Failure; RAAS Blockade in Ethnic Minorities with Chronic Kidney Disease: A United Kingdom Perspective; Use of ACE Inhibitors & Angiotensin-2 Receptor Blockers in the Management of the Cardio-Renal Syndrome; A Three-Year Clinical Experience with ACE Inhibitors at Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria, Department of Pediatrics, 2010-2012; Is There a Role for ACEIs in the ICU?; The Impact of ACE Inhibition in the Management of Sickle Cell Disease in Nigerian Adults; Hypertension-Misattributed Kidney Disease in African Americans; Treatment of Infantile Hemangioma with An ACE Inhibitor: A Paradigm Shift; Epilogue - Bold Predictions on the Future of Renoprotection: The Way Forward with Multiple Pathway ; Blockers Making a Case For Novel Non-Angiotensin Inhibiting Renoprotective Agents like Corticotropin & Pentoxifylline; Index.